Healthcare Glossary

SUGGEST A NEW TERMCONTACT US

Healthcare terms - Terms A-Z

• Global Health Observatory
• National Institute for Health and Clinical Excellence
• (Chartered) Institute of Public Relations (IPR)
• Abbreviated advertisement (UK)
• Above the fold
• Above the line
• ABPI Code of Practice
• Account management
• Accreditation Council for Continuing Medical Education (ACCME)
• Accredited programmes
• ACE PR Value
• Acute care
• Ad concept testing
• Ad impression
• Ad recall
• Ad rotation
• Ad tracking research
• Adaptive scripting
• Added value
• Adherence
• Adopter categories
• Adoption curve
• Adverse reaction
• Advertising
• Advertising agency's commission
• Advertising research
• Advertorial
• Advocacy
• Advocacy and support groups
• Affiliate marketing
• Affinity marketing
• Alpha/beta testing
• Alternative service providers (ASP)
• Ambient media
• Ambulatory Care and Diagnostics Centre (ACAD)
• American Medical Association (AMA)
• Ansoff Matrix
• Arm
• Asset-led marketing
• Association of the British Pharmaceutical Industry (ABPI)
• Asymptomatic
• Attention, interest, desire, action (AIDA)
• Attitude Awareness Usage Study (AAU)
• Attitudinal scaling
• Audit
• Audit Bureau of Circulation (ABC)
• Australian Medical Association (AMA)
• Awareness, interest, understanding, attitudes, purchase, repeat purchase (AIUAPR)
• Background
• Background Factors
• Balanced Scorecard
• Banner Ad.
• Baseline
• Behavioural targeting
• Below the line
• Beta Tests
• Bias
• Big pharma
• Black space
• Blanket coverage
• Blended e-learning
• Blind (clinical trial terms)
• Boilerplate
• Boston matrix
• Brainstorm
• Brand
• Brand extension
• Brand image
• Brand management
• Brand mapping
• Brand personality
• Brand reinforcement
• Brand revitalisation
• Brand strategy
• Brand value
• Branding ladder
• Brief summary
• British Medical Association (BMA)
• British National Formulary (BNF)
• British Pharmacological Society (BPS)
• Broadsheet
• Business plan
• Business portfolio
• Business strategy
• Business to business (B2B)
• Business to consumer (B2C)
• Buying behaviour
• Buzz
• Byline
• Campaign
• Campaign plan
• Capital
• Cardiothoracic
• Cartel
• Cash cow
• Category management
• Cause-related marketing
• Central nervous system (CNS)
• Channel marketing
• Channel strategy
• Channels
• Chief Medical Officer (CMO)
• Chronic disease
• Circulation
• Click through rate (CTR)
• Click tracking
• Clinical
• Clinical trial
• Clinical trial enrolment
• Clip or Clipping
• Closed systems
• Co-operative
• Cognitive dissonance
• Cohort
• Collateral PR
• Column inches
• Commission on Human Medicines (CHM)
• Commissioning (health)
• Committee for Medicinal Products for Human Use (CHMP)
• Community care
• Company-specific training
• Comparative advertising
• Compassionate use
• Competitive advantage
• Competitor analysis
• Competitors
• Compliance
• Computer-assisted telephone interviewing or computer-aided telephone interviewing (CATI)
• Concept boards
• Concept development and testing
• Concordance
• Concordance programme
• Confidence level
• Conflict of interest
• Congenital
• Conjoint analysis
• Construct
• Consumer
• Consumer behaviour
• Contextual marketing
• Continuing Medical Education (CME)
• Continuing professional development (CPD)
• Contraindication
• Control group
• Controlled trial
• Convenience sampling
• Conversion rate
• Copy editor
• Copyright
• Copywriting
• Core message
• Corporate fact sheet
• Corporate governance
• Corporate identity
• Corporate reputation
• Corporate social responsibility (CSR)
• Corporate strategy
• Cost consequences analysis (CCA)
• Cost leadership
• Cost per acquisition/action (CPA)
• Cost per click (CPC)
• Cost per thousand (CPM)
• Cost utility analysis (health economics)
• Cost-effective (healthcare economics)
• Cost-effectiveness (in media/advertising)
• Cost-effectiveness analysis (health economics)
• Cost-effectiveness league table (healthcare economics)
• Cost-effectiveness threshold (health economics)
• Cost-minimisation analysis (CMA)
• Cost–benefit analysis
• Counterfeiting
• Coverage
• Creative director
• Creatives
• Crisis management
• Critical success factors
• Culture
• Customer
• Customer focus
• Customer lifetime value (CLV)
• Customer loyalty
• Customer relationship management (CRM)
• Customer satisfaction
• Customer service
• Customer service programme
• Customised marketing mix
• Data analysis
• Data cleansing
• Data collection
• Data entry
• Data fusion
• Data mining
• Data processing
• Data Protection Act
• Data sheet
• Database marketing
• Day-after recall
• Decision flow diagram
• Decision making unit (DMU)
• Decision tree
• Decline Stage
• Deduping
• Deep linking
• Defined daily dose (DDD)
• Defining Advertising Goals for Measured Advertising Response (DAGMAR)
• Delegate
• Demand bias
• Demand curve
• Demographic data
• Demographics
• Department of Health (DH)
• Depth interview
• Desired outcomes
• Detail aid
• Diagnostic trials
• Dichotomous question
• Differentiation
• Digital creative
• Direct mail
• Direct marketing
• Direct response advertising (DRA)
• Direct-to-consumer (DTC)
• Discounted cash flow (DCF)
• Discussion guide
• Disease awareness marketing
• Disease mongering
• Display advertisement
• Disposable income
• Distance learning
• Distribution
• Diversification
• Dodo
• Dog
• Dose-ranging trial
• Double page spread (DPS)
• Double-blind trial
• DRIP Framework
• Drivers
• Drop out
• Drug tariff
• Drug usage/utilisation review (DUR)
• Drug-drug interaction
• Duplication
• e-Commerce
• e-Detailing
• e-Learning
• e-Marketing
• e-Prescribing
• e-Sampling
• Early adopters
• Early majority
• Economic evaluation
• Economic regulation
• Economic value added (EVA)
• Editing
• Editor
• Editorial
• Editorial calendar
• Effectiveness
• Efficacy
• Efficiency
• Efficient consumer response (ECR)
• Eighty-twenty principle (Pareto Principle)
• Elective care
• Electronic point of sale (EPOS) system
• Eligibility criteria
• Emotional selling preposition (ESP)
• Empirical
• Endemic
• Endorsement
• Endpoint
• Entrepreneur
• Environmental scanning
• Environmental set
• Epidemiology
• Equivalent advertising value (EAV)
• European Accreditation Council for CME (EACCME)
• European Association of Communications Agencies (EACA)
• European Federation of Pharmaceutical Industries (EFPIA)
• European Foundation for Quality Management (EFQM)
• European Medicines Agency
• European Union (EU)
• European Union of Medical Specialists (UEMS)
• Exclusive
• Executive summary
• Expanded access
• Experimental drug
• Export marketing
• External analysis
• Fair balance
• Fast Moving Consumer Goods (FMCG)
• Fax Preference Service (FPS)
• Feature article
• Fees
• Field experiments
• Field marketing
• Focus group moderator
• Focus groups
• Focused Advertising Sampling Technique (FAST) Marketing
• Font
• Food And Drug Administration (FDA)
• Forecasting
• Formulary
• Foundation Trust (FT)
• Four Ms
• Four Ps
• Franchising
• Free market economy
• Freelancer
• Frequency
• Full-service agency
• Gatekeeper
• General practitioner (GP)
• Generic medicine
• Generic name
• Genome
• Geo-demographics
• Glass ceiling
• Global brand
• Global Health Index
• Global marketing
• Grey market
• Grey marketing (also called parallel importing)
• Greying, leisured, affluent, middle-aged (GLAM)
• Gross Domestic Product (GDP)
• Group dynamics
• Growth stage
• Guarantees and warranties
• Guerrilla marketing
• Guppie
• Gutter
• Hard sell
• Health Care Financing Administration (HCFA) (US)
• Health Care prepayment plan (HCPP) (US)
• Health economics
• Health Maintenance Organisation (HMO)
• Health profile
• Health state
• Health Status Index
• Health Status Instrument (Pharmacoeconomics)
• Health Status Measure
• Health technology assessment/appraisal (HTA)
• Health-related Quality of QOL
• Healthcare Communications Association (HCA)
• Healthy years equivalent (HYE)
• Hierarchy of Needs
• Homogeneous groups
• Horizon scanning
• Hypothesis
• i-Coach
• In-Company training
• In-house
• In-house newspaper/magazine
• Inclusion/exclusion criteria
• Incremental cost-effectiveness ratio (ICER)
• Indication
• Inducements
• Industrial marketing
• Infant
• Infiltration marketing
• Informed consent
• Informed consent document
• Institute of Practitioners in Advertising (IPA)
• Institutional review board (IRB) - pharmacoeconomics
• Intent to treat
• Internal analysis
• Internal communications
• Internal Customers
• Internal marketing
• Internal relations officer (IRO)
• International Clinical Trial Registry Platform (ICTRP)
• International Committee of Medical Journal Editors (ICMJE)
• International marketing
• International nonproprietary name (INN)
• International Public Relations Association (IPRA)
• Interventions - clinical
• Intrapreneur
• Intrapreneurship
• Investigational new drug (IND)
• Joint venture
• Key account management
• Key opinion leader (KOL)
• Key performance indicator (KPI)
• Key success factor (KSF)
• Knowledge management
• Labelling
• Ladder of loyalty
• Latent click through
• Latent demand
• Launch
• Launch plan
• Layout
• Lead generation
• Lead management
• Leader article
• Leader pricing
• Learning curve
• Learning log
• License (product)
• License agreement
• Licensed
• Life cycle (product)
• Lifestyle
• Lifestyle drug
• Lifestyle research
• Likert scale
• Line extension
• List broker
• List building
• List price
• Literature search
• Loaded question
• Lobby
• Lobby firm
• Local advertising
• Logistics
• Logo
• Long term value (LTV)
• Long-range planning
• Loss leader
• Macro environment
• Maintenance strategy
• Majority fallacy
• Managed care
• Management by objectives (MBO)
• Margin (profit)
• Marginal analysis
• Marginal cost
• Market attractiveness
• Market challenger
• Market development
• Market entry
• Market entry barrier
• Market follower
• Market forecast
• Market growth rate
• Market leader
• Market niche
• Market penetration
• Market penetration pricing
• Market penetration strategy
• Market positioning
• Market research
• Market segmentation
• Market share
• Market skimming pricing
• Market value added (MVA)
• Marketing
• Marketing acronyms
• Marketing advantage
• Marketing audit
• Marketing channels
• Marketing communications
• Marketing concept
• Marketing consultant
• Marketing cost analysis
• Marketing decision support system (MDSS)
• Marketing information
• Marketing intelligence
• Marketing metrics
• Marketing mix
• Marketing myopia
• Marketing objectives
• Marketing orientation
• Marketing plan
• Marketing planning
• Marketing research (MR)
• Marketing strategy
• Marketing strategy
• Mathematical analysis of perception and preference (MAPP)
• Maturation
• McKinsey Seven S's of Management (or 7-S Model)
• Me-too
• Mean
• Media buyer
• Media evaluation
• Media mix
• Media planning
• Media schedule
• Medicines and Healthcare products Regulatory Agency (MHRA)
• Merchandising
• Merger and Acquisition (M&A)
• Meta analysis
• Methodology
• Micro environment
• Microsite
• Mission statement
• Mobile commerce (M-Commerce)
• Mode
• Modelling
• Models (or marketing models)
• Moderator
• Moderator guide
• Modular training
• Monopoly
• Monopsony
• Mood board
• Morbidity
• Mores
• Motivation research
• Moving annual total (MAT)
• Multi-brand strategy
• Multimedia
• Narrowcasting
• National Change of Address (NCOA)
• National Health Service (NHS)
• National Institute for Health and Clinical Excellence (NICE)
• National Readership Survey (NRS)
• National Service Frameworks (NSF)
• Negative demand
• Neuromarketing
• New Drug Application (NDA)
• New product development (NPD)
• Newspaper Licensing Agency (NLA)
• NHS Direct
• NHS Evidence
• NHS Executive
• Niche marketing
• Non-comparative
• Non-profit marketing
• Nonverbal communications
• Normal distribution
• Normative influence
• Norms
• Objectives
• Off-label use
• Offensive marketing
• Oligopsony
• Omnibus survey
• One to one marketing (1:1 marketing)
• One-on-one interview
• Online learning
• Open ended question
• Open observation
• Open-label trial
• Opinion leader
• Opportunities to hear (OTH)
• Opportunities to see (OTS)
• Opportunity cost
• Optimising
• Order bias
• Organic growth/development
• Orphan drugs
• Outlier
• Outsourcing
• Over the counter (OTC)
• Packaging
• Pandemic
• Parallel importing
• Pareto principle
• Patent
• Payback period
• Payment by results (PBR)
• Peer review
• Peer to peer (P2P) marketing
• PEEST
• Penetrated market
• Penetration pricing
• Perfect competition
• Performance prism
• Persistence
• Personal data
• Personal selling
• PESTLE
• Pharmaceutical Pricing Regulation Scheme (PPRS)
• Pharmaceutical Researchers and Manufacturers of America (PhRMA)
• Pharmacokinetics
• Pharmacy Benefit Manager (PBM)
• Phase I trials
• Phase II trials
• Phase III trials
• Phase IV trials
• Pilot programme
• Placebo
• Placebo effect
• Placebo-controlled trial
• Point of sale (POS)
• Point-of-purchase displays
• Porter's 'Five Forces'
• Portfolio
• Portfolio analysis
• Positioning
• Post detail survey
• Post-testing
• Practice Based Commissioning (PBC)
• Pre-clinical trials
• Preferred provider organisation (PPO)
• Premium pricing
• Prescribing Analysis and Cost (PACT)
• Prescribing information
• Prescription Medicines Code of Practice Authority (PMCPA)
• Prescription only medicine (POM)
• Press release
• Prevention trials
• Price fixing
• Price maker
• Price taker
• Primary care
• Primary Care Trust (PCT)
• Prior approval
• Procurement officer/manager
• Product attributes
• Product class
• Product differentiation
• Product pipeline
• Promotional mix
• Promotional plan
• Prompted recall
• Prophylaxis
• Proprietary name
• Protocol
• Public relations
• Publication planning
• Publics
• Pull promotion
• Purchasing power parities (PPP)
• Push promotion
• Qualitative research
• Quality assurance programme
• Quality of life (QOL)
• Quality of life trials
• Quality-adjusted life year (QALY)
• Quantitative objectives
• Quantitative research
• Quota
• Random samplings
• Randomisation
• Randomised trial
• Range
• Rate card
• Reach
• Readership
• Recall test
• Recession
• Reciprocal links
• Recognition tests
• Recruiting
• Recruitment status
• Reference group
• Reference pricing
• Registered trademark
• Regression analysis
• Reimbursement
• Reinforcement advertising
• Relationship marketing
• Relative advantage
• Relative market share
• Repositioning
• Reprint
• Research and development (R&D)
• Research proposal
• Respondent
• Respondent fatigue
• Response bias
• Response rate
• Responsiveness
• Return on equity (ROE)
• Return on investment (ROI)/Return on capital employed (ROCE)
• Return on sales enablement (ROSE)
• Risk analysis
• Risk-benefit analysis
• Routine response behaviour
• Royal Pharmaceutical Society of Great Britain (RPSGB)
• RSS
• Safety assessment of marketed medicines studies (SAMM)
• Sales promotion
• Sample (market research)
• Sampling
• Scamp
• Screening trials
• Search engine marketing (SEM)
• Search engine optimisation (SEO)
• Search engine ranking
• Secondary care
• Seeding trial
• Segment
• Segmentation
• Segmentation strategies
• Sensitive data
• Sensitivity analysis (pharmacoeconomics)
• Sensitivity to change (pharmacoeconomics)
• Shareholder value
• Shelf life
• Side-effects
• Single-blind trial
• Situation analysis
• Skimming
• Small to medium enterprise (SME)
• SMART objectives
• Social audit
• Social marketing
• Social media
• Socially responsible marketing
• Spam
• Special interest groups
• Sponsorship
• Stakeholder
• Standard of care
• Standard treatment
• Statistical significance
• Strategic business unit (SBU)
• Strategic health authority (SHA)
• Strategic marketing concept
• Subscriber list
• Substantiation
• Supplier relationship management (SRM)
• Supply chain
• SWOT analysis
• Syndicate groups
• Syndicated market research data
• Tactical planning
• Tagging
• Target audience
• Target publications
• Tariffs
• Technical efficiency (pharmacoeconomics)
• Telesales
• Terms and conditions of purchase
• Terms and conditions of sale
• Territory
• Territory management
• Test marketing
• Testimonials
• Therapy area
• Tonal bias
• Tone of the media
• Top-of-mind awareness (TOMA)
• Toxicity
• Trade advertising
• Trade allowance
• Trade barriers
• Trade publications
• Trademark
• Transfer price
• Treatment Investigational New Drug (IND)
• Treatment trials
• Treatment trials
• Trend analysis
• Trial endpoint
• Trial stage
• Umbrella pricing
• Unique page views
• Unique selling preposition (USP)
• Unique visitor
• United States adopted name (USAN)
• Unplanned cannibalisation
• Unprompted recall
• Unstructured observation
• Unstructured question
• Unsubstantiated claims
• User session
• Utility (pharmacoeconomics)
• Utility weighted index
• Value preposition
• Variability
• Variable
• Variance
• Verbatim
• Verified data
• Vertical integration
• Video focus groups
• Viewing room
• Viral marketing
• Virtual community
• Vision
• World Health Organisation (WHO)
• “P” Medicine

• Most read
• Most shared
• Latest content